Dr. Gary Gesualdi is recognized among the nation’s leading injectors and was handpicked to join an elite group of cosmetic physicians to receive early training and authorization to provide VOLUMA, ...
At 3 months, findings showed 80.4% of patients treated with Juvéderm Voluma XC achieved at least a 1-point improvement in moderate to severe temple hollowing. The Food and Drug Administration (FDA) ...
As we age, the effects of time and gravity can be written all over our faces. Once-full cheeks can droop - and with that, so can self-confidence. At 44 years old, Mandy Craft has tried makeup and ...
IRVINE, Calif.--(BUSINESS WIRE)--Allergan, Inc., (NYSE:AGN) today announced that the company has received approval from the U.S. Food and Drug Administration (FDA) to market JUVÉDERM VOLUMA™ XC, the ...
(RTTNews) - Allergan plc (AGN) said that it received U.S. Food and Drug Administration approval for the use of Juvéderm VOLUMA XC, a hyaluronic acid gel dermal filler, with a TSK STERiGLIDE cannula ...
Dermatologists and plastic surgeons have a new, nonsurgical weapon to add to their anti-aging arsenal. Juvéderm Voluma XC was approved by the U.S. Food and Drug Administration in December as the first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results